Pfizer Global Research and Development, Department of Discovery Biology, Sandwich, UK Purpose: The present study was designed to determine whether the activity of voriconazole (VOR), a novel triazole, was reduced against candidal and cryptococcal infections by the addition of standard antifungal agents, amphotericin B (AMB) and 5-fluorocytosine (5-FC).